Lantern Pharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Lantern Pharma's balance sheet done over the years? Its assets were worth $43,647,616 last year, which is less than in the previous period. 6% of Lantern Pharmaโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $2,739,682, which means an decrease by -2% compared compared to last year.

Debt to Assets

Lantern Pharma Inc. (NASDAQ:LTRN): Debt to assets
2018 449831 651.62K 144.86%
2019 1432576 489.29K 34.15%
2020 20359634 660.83K 3.25%
2021 73950477 2.37M 3.22%
2022 58836321 2.79M 4.76%
2023 43647616 2.73M 6.28%

LTRN Balance Sheet (2018 โ€“ 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
21.93M37.20M51.52M19.22M1.23M445.16K
Short term investments
19.36M17.99M19.20M000
Net receivables
0592K181K000
Inventory
0-592K-181K000
Other current assets
1.60M3.52M1.99M1.00M7880
Total current assets
43.34M58.72M72.71M20.23M1.23M445.16K
Non-current assets:
Property, Plant and Equipment
280.42K95.69K216.18K21.50K8.75K4.66K
Goodwill
000000
Intangible assets
000000
Long term investments
001M000
Other non-current assets
25.86K17.88K17.88K101.20K191K0
Total non-current assets
306.29K113.58K1.23M122.71K199.75K4.66K
Total assets
43.64M58.83M73.95M20.35M1.43M449.83K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0-2.74M-2.17M000
Short term debt
172.97K52.89K152.05K000
Total current liabilities
2.67M2.79M2.32M552.33K489.29K651.62K
Non-current liabilities:
Long term debt
61.49K52.89M52.89K108.5K00
Deferred tax
000000
Other non-current liabilities
0-52.83M-1-100
Total non-current liabilities
61.49K52.89K52.89K108.5K00
Total liabilities
2.73M2.79M2.37M660.83K489.29K651.62K
Data sourceData sourceData sourceData source